ARTICLE | Clinical News
Pixantrone regulatory update
January 4, 2010 8:00 AM UTC
EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for pixantrone dimaleate to treat diffuse large B cell lymphoma. Cell Therapeutics expe...